SBIR-STTR Award

Auto Injector Administration of Ketamine for Critically Injured Airmen
Award last edited on: 6/2/2023

Sponsored Program
STTR
Awarding Agency
DOD : AF
Total Award Amount
$799,987
Award Phase
2
Solicitation Topic Code
AF21B-TCSO1
Principal Investigator
Jessica Walsh

Company Information

Rx Bandz LLC

1605 Lakecliff Lane Suite 100
Austin, TX 78732
   (617) 827-6253
   N/A
   www.rxbandz.com

Research Institution

Metis Foundation

Phase I

Contract Number: FA864922P0072
Start Date: 11/5/2021    Completed: 2/7/2022
Phase I year
2022
Phase I Amount
$49,999
MiniJectTM is a versatile intramuscular (IM) auto-injector that is critically important when warfighters require medication, such as Ketamine, the battlefield anaesthetic of choice for casualties in severe pain/shock/respiratory distress, or at significan

Phase II

Contract Number: FA8649-22-P-1153
Start Date: 7/20/2022    Completed: 10/20/2023
Phase II year
2022
Phase II Amount
$749,988
MiniJect® is a versatile intramuscular (IM) auto-injector that is critically important when warfighters require medication, such as Ketamine, the battlefield anaesthetic of choice for casualties in severe pain/shock/respiratory distress, or at significant risk of these conditions. The DoD, following recommendations from the TCCC, has highlighted ketamine as a preferred alternative to morphine in the field. With MiniJect®, ketamine can be delivered faster, more accurately and reliably intramuscularly than via vial and syringe which is suboptimal for the chaos on the battlefield. MiniJect® is the size of a large thumb-drive and easily fits into a pocket or attaches to a belt. Its features - impact resistant, IR/UV-shielded, waterproof – are well suited to austere conditions, including deployed settings and outside the wire operations.